期刊文献+

以关节炎为首发表现的银屑病关节炎的临床特征 被引量:7

The clinical characters of psoriatic arthritis which antedates psoriasis
原文传递
导出
摘要 目的 分析以关节炎为首发表现的银屑病关节炎 (PA)的临床特征。方法 对 15例以关节炎为首发表现的PA的临床体征、实验室及放射学特点进行分析。结果  15例PA患者中 ,男性 11例 ,女性 4例 ,男女之比为 2 75∶1。发病年龄 11~ 4 7岁 ,平均 (2 4± 13)岁 ,病程 2个月~ 30年 ,平均 (11± 15 )年 ,关节炎和皮疹间隔时间为 2个月~ 30年 ,平均 (9± 9)年。HLA B2 7阳性者 13例 ,有骶髂关节炎者 10例。结论 以关节炎为首发表现的PA患者骶髂关节受累多 ,并与HLA B2 7有一定相关。 Objective To analyze the clinical characters of psoriatic arthritis (PA) which antedates psoriasis.Method The clinical characters,laboratory tests and radiographic findings of fifteen PA patients whose arthritis antedated psoriasis were analyzed.Results The male to female ratio was 2 75∶1,the age of onset was 11 to 47 years.The course was 2 month to 30 years.HLA B27 was positive in 86 7%(13/15) of patients and sacroiliitis on X ray was noted in 10 patients.Conclusion There are more sacroiliitis in PA patients whose arthritis antedates psoriasis and they are associated with HLA B27.
出处 《中华风湿病学杂志》 CAS CSCD 2003年第4期201-203,共3页 Chinese Journal of Rheumatology
关键词 关节炎 首发表现 银屑病 关节炎 临床特征 HLA-B27抗原 Arthritis,psoriatic Sacroiliac joint HLA B27 antigen
  • 相关文献

参考文献8

  • 1Bennett RM.Psoriatic arthritisIn,1992.
  • 2Moll JM;Wright V.Psoriatic arthritis[J],1973.
  • 3Gladman DD;Shuckett R;Russell ML.Psoriatic arthritis:an analysis of 220 patients,1987.
  • 4Kammer GM;Soter NA;Gibson DJ.Psoriatic arthritis:a clinical immunologic and HLA study of 100 patients[J],1979.
  • 5Battistone MJ;Manaster BJ;Reda DJ.The prevalence of sacroiliitis in psoriatic arthritis:new perspectives from a large,multicenter cohort.A Department of Eterans Affairs Cooperative Study[J],1999.
  • 6张江林,黄烽,刘湘源.银屑病关节炎临床特点及与HLA-B27的相关性研究[J].中华风湿病学杂志,1999,3(2):87-89. 被引量:23
  • 7Vaquero CG;Moreno JR;Ros S.Termination of disease-modifying drugs in psoriatic arthritis:study of 109 courses of treatment,1996.
  • 8Wagner SA;Peter RU;Adam O.Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis[J],1993.

共引文献22

同被引文献77

  • 1张改连,黄烽.银屑病关节炎药物治疗新进展[J].中国药物应用与监测,2006,3(6):15-19. 被引量:9
  • 2梁东风,黄烽.抗TNF-α疗法治疗银屑病关节炎和银屑病[J].中国药物应用与监测,2005,2(3):39-42. 被引量:6
  • 3何坚,唐福林.银屑病关节炎的药物治疗[J].中华风湿病学杂志,2004,8(11):690-692. 被引量:6
  • 4吴华香,李军,郑敏.银屑病关节炎的临床特征和治疗[J].中华皮肤科杂志,2005,38(3):170-171. 被引量:8
  • 5王磊,王宝玺.银屑病性关节炎的治疗进展[J].中国皮肤性病学杂志,2006,20(6):372-375. 被引量:11
  • 6[4]Moll J,Wright V.Psoriatic arthritis[J].Seminars Arthritis Rheum,1973,3:55.
  • 7[5]Mease P.TNF-o therapy in psoriatic arthritis and psoriasis:how and why does it work[J].Ann Rheum Dis,2004,63(7) :755.
  • 8[6]Genovese MC,Bathon JM,Martin RW,et al.Etanercept versus methotrexate in patients with early rheumatoid arthritis:2-year radiographic and clinical outcomes[J].Arthritis Rheum,2002,46:1443.
  • 9[7]Furst DE,Schiff MH,Fleischmann RM,et al. Adalimumab,a fully human anti-tumor necrosis factor-alpha monoclonal antibody, and concomitant standard anti-rheumatic therapy for the treatment of rheumatoid arthritis:results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)[J].J Rheumatol,2003,30: 2563.
  • 10[8]Mease PJ,Goffe BS,Metz J,et al. Etanercept in the treatment of psoriatic arthritis and psoriasis:a randomized trial[J].Lancet,2000,356: 385.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部